Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 49.98 USD -2.61% Market Closed
Market Cap: $2.2B

Operating Margin

1.5%
Current
Improving
by 1.9%
vs 3-y average of -0.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.5%
=
Operating Income
$17.1m
/
Revenue
$1.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.5%
=
Operating Income
$17.1m
/
Revenue
$1.2B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Omnicell Inc
NASDAQ:OMCL
2.3B USD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
36.5B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
18.9B AUD
Loading...
JP
M3 Inc
TSE:2413
1.4T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
7.6B USD
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
5.2B USD
Loading...
SE
Sectra AB
STO:SECT B
43.2B SEK
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
26.7B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
283.3B INR
Loading...
US
Heartflow Inc
NASDAQ:HTFL
2.8B USD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
39th
Based on 14 112 companies
39th percentile
1.5%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Omnicell Inc
Glance View

Omnicell Inc. stands at the intersection of healthcare and technology, sculpting the landscape of medication management systems with its innovative spirit. Founded in 1992, Omnicell has evolved from a small enterprise into a leading provider of automated solutions for medication and supply dispensing, inventory management, and analytics. The company’s core offering, its automated dispensing systems, reshapes how hospitals, pharmacies, and healthcare providers manage medications. By utilizing cutting-edge technology, Omnicell improves efficiency, reduces medication errors, and cuts down on healthcare costs. These systems are embedded in the workflow of healthcare facilities, ensuring that medication management becomes seamless, thus elevating patient safety and clinical outcomes. Revenue streams flow robustly from both product sales and associated services. Omnicell garners income by selling its advanced hardware systems, which include everything from pharmacy carousels to medication robotic systems, and supplements these sales with software solutions that offer predictive analytics and inventory optimization. Beyond the initial sale, a significant part of their business model includes recurring revenue through service contracts, software updates, and customer support. This dual approach not only ensures a steady cash flow but also strengthens customer relationships by consistently providing value over time. As the healthcare industry increasingly leans on technology for streamlined operations and cost management, Omnicell’s strategic positioning allows it to capitalize on the demand for sophisticated medication management solutions.

OMCL Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
1.5%
=
Operating Income
$17.1m
/
Revenue
$1.2B
What is Omnicell Inc's current Operating Margin?

The current Operating Margin for Omnicell Inc is 1.5%, which is above its 3-year median of -0.5%.

How has Operating Margin changed over time?

Over the last 3 years, Omnicell Inc’s Operating Margin has decreased from 4% to 1.5%. During this period, it reached a low of -2.4% on Jun 30, 2024 and a high of 4% on Aug 30, 2022.

Back to Top